Laura Marie Nally, MD
Assistant Professor of Pediatrics; Assistant Professor, Pediatric Endocrinology & Diabetes
Research & Publications
Biography
News
Research Summary
Since my diagnosis of type 1 diabetes at the age of 6, I have witnessed first-hand some of the most incredible technological advances in diabetes care. From the development of faster, more accurate glucometers, rapid acting insulin, insulin pump therapy, and continuous glucose monitoring systems, each of these new developments has greatly improved my quality of life.
Extensive Research Description
My current research involves studying how dietary factors affect glycemic control in type 1 diabetes. I am also interested in looking at psychosocial factors that affect chronic illness management, and using behavioral interventions to help adolescents cope with and manage type 1 diabetes. Further, with the rising out of pocket cost for diabetes medications, I am interested in evaluating how individuals successfully navigate our healthcare system and how we can potentially improve the healthcare system.
Coauthors
Selected Publications
- 60-LB: Social Media as a Last Resort—Barriers to Accessing Diabetes Medications and SuppliesHAREL S, WILCOX A, LUKASIK J, SUTTIRATANA S, LIPSKA K, WEINZIMER S, GUJRAL J, NALLY L. 60-LB: Social Media as a Last Resort—Barriers to Accessing Diabetes Medications and Supplies. Diabetes 2023, 72 DOI: 10.2337/db23-60-lb.
- Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot studyNally L, Sherr J, Tichy E, Weyman K, Urban A, Shabanova V, McCollum S, Steffen A, Tamborlane W, Van Name M. Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabetic Medicine 2023, 40: e15123. PMID: 37078999, PMCID: PMC10524154, DOI: 10.1111/dme.15123.
- Personalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 DiabetesAsh G, Nally L, Stults-Kolehmainen M, De Los Santos M, Jeon S, Brandt C, Gulanski B, Spanakis E, Baker J, Weinzimer S, Fucito L. Personalized Digital Health Information to Substantiate Human-Delivered Exercise Support for Adults With Type 1 Diabetes. Clinical Journal Of Sport Medicine 2023, 33: 512-520. PMID: 36715983, PMCID: PMC10898917, DOI: 10.1097/jsm.0000000000001078.
- Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot studyNally, LM, Sherr, JL, Tichy, E, et al. Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabet Med. 2023; 00:e15123. doi:10.1111/dme.15123
- Navigating barriers to affording and obtaining insulin and diabetes suppliesWilcox A, Lipska K, Weinzimer S, Gujral J, Arakaki A, Kerandi L, Nally L. Navigating barriers to affording and obtaining insulin and diabetes supplies. Journal Of Diabetes 2022, 15: 71-75. PMID: 36562281, PMCID: PMC9870729, DOI: 10.1111/1753-0407.13344.
- Abstract 13573: Machine Learning to Identify Predictors of Lapses in a Beginners’ Exercise Program for Adults With Type 1 DiabetesDoshi R, Liu J, Jeon S, Businelle M, Hebert E, Nally L, Stults-Kolehmainen M, Fucito L, Weinzimer S, Gerstein M, Ash G, Stults-Kolehmainen M. Abstract 13573: Machine Learning to Identify Predictors of Lapses in a Beginners’ Exercise Program for Adults With Type 1 Diabetes. Circulation 2022, 146: a13573-a13573. DOI: 10.1161/circ.146.suppl_1.13573.
- Feasibility and Preliminary Safety of Smartphone-Based Automated Insulin Delivery in Adolescents and Children With Type 1 DiabetesDeshpande S, Weinzimer SA, Gibbons K, Nally LM, Weyman K, Carria L, Zgorski M, Laffel LM, Doyle FJ, Dassau E. Feasibility and Preliminary Safety of Smartphone-Based Automated Insulin Delivery in Adolescents and Children With Type 1 Diabetes. Journal Of Diabetes Science And Technology 2022, 18: 363-371. PMID: 35971681, PMCID: PMC10973844, DOI: 10.1177/19322968221116384.
- 1025-P: Racial Disparities in Diabetes Distress and Technology Use in Adolescents with Type 1 DiabetesWILCOX A, MENCHER S, NALLY L, WEINZIMER S. 1025-P: Racial Disparities in Diabetes Distress and Technology Use in Adolescents with Type 1 Diabetes. Diabetes 2022, 71 DOI: 10.2337/db22-1025-p.
- Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making ProcessMencher SR, Weinzimer SA, Nally LM, Van Name M, Nunez-Smith M, Sadler LS. Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making Process. Diabetes Technology & Therapeutics 2022, 24: 249-257. PMID: 35085444, DOI: 10.1089/dia.2021.0413.
- Qualitative Study of User Experiences With Loop, an Open-Source Automated Insulin Delivery SystemNally LM. A commentary on: Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/qualitative-study-of-user-experiences-with-loop-an-open-source-automated-insulin-delivery-system/138310/65/8/1. Accessed July 21, 2022
- Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System.Waikar AR, Arora T, Haynes M, Tamborlane WV, Nally LM. Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System. Clinical Diabetes 2021, 39: 441-444. PMID: 34866788, PMCID: PMC8603326, DOI: 10.2337/cd20-0128.
- Establishing a Global Standard for Wearable Devices in Sport and Exercise Medicine: Perspectives from Academic and Industry StakeholdersAsh GI, Stults-Kolehmainen M, Busa MA, Gaffey AE, Angeloudis K, Muniz-Pardos B, Gregory R, Huggins RA, Redeker NS, Weinzimer SA, Grieco LA, Lyden K, Megally E, Vogiatzis I, Scher L, Zhu X, Baker JS, Brandt C, Businelle MS, Fucito LM, Griggs S, Jarrin R, Mortazavi BJ, Prioleau T, Roberts W, Spanakis EK, Nally LM, Debruyne A, Bachl N, Pigozzi F, Halabchi F, Ramagole DA, Janse van Rensburg DC, Wolfarth B, Fossati C, Rozenstoka S, Tanisawa K, Börjesson M, Casajus JA, Gonzalez-Aguero A, Zelenkova I, Swart J, Gursoy G, Meyerson W, Liu J, Greenbaum D, Pitsiladis YP, Gerstein MB. Establishing a Global Standard for Wearable Devices in Sport and Exercise Medicine: Perspectives from Academic and Industry Stakeholders. Sports Medicine 2021, 51: 2237-2250. PMID: 34468950, PMCID: PMC8666971, DOI: 10.1007/s40279-021-01543-5.
- 917-P: Supervised Basal Insulin Injections Prevent Ketosis in Youth with Type 1 Diabetes (T1D)NALLY L, SOSNOSKI O, SHERR J, TICHY E, WEYMAN K, STEFFEN A, MCCOLLUM S, SHABANOVA V, TAMBORLANE W, VAN NAME M. 917-P: Supervised Basal Insulin Injections Prevent Ketosis in Youth with Type 1 Diabetes (T1D). Diabetes 2021, 70 DOI: 10.2337/db21-917-p.
- 49-LB: Navigating Barriers to Affording and Obtaining Diabetes TreatmentWILCOX A, KERANDI L, LIPSKA K, WEINZIMER S, NALLY L. 49-LB: Navigating Barriers to Affording and Obtaining Diabetes Treatment. Diabetes 2021, 70 DOI: 10.2337/db21-49-lb.
- Plasmapheresis as an Early Treatment for Severe Hypertriglyceridemia, Acute Pancreatitis, and Diabetic KetoacidosisKravetz AM, Sanghavi P, Bhargava V, Shi RZ, Nally LM. Plasmapheresis as an Early Treatment for Severe Hypertriglyceridemia, Acute Pancreatitis, and Diabetic Ketoacidosis. AACE Clinical Case Reports 2021, 7: 315-319. PMID: 34522772, PMCID: PMC8426612, DOI: 10.1016/j.aace.2021.03.009.
- The Influence of Health Mindset on Perceptions of Illness and Behaviors Among AdolescentsJohn-Henderson NA, Wright RC, Manke KJ, Fotuhi O, Zuckerman B, Nally L, Mueller CM. The Influence of Health Mindset on Perceptions of Illness and Behaviors Among Adolescents. International Journal Of Behavioral Medicine 2021, 28: 727-736. PMID: 33721232, DOI: 10.1007/s12529-021-09972-2.
- Adjunctive Therapies for Type 1 DiabetesNally L, Van Name M, Tamborlane W, Sherr J. Adjunctive Therapies for Type 1 Diabetes. 2021, 143-150. DOI: 10.1007/978-3-030-64133-7_13.
- Open-Source Automated Insulin DeliveryCommentary "Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals"
- A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics InterventionNally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, Zajac K, Desousa M, Shabanova V, Petry NM, Tamborlane WV, Van Name M. A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention. Endocrine Practice 2020, 27: 545-551. PMID: 34120699, PMCID: PMC8206518, DOI: 10.1016/j.eprac.2020.11.017.
- Expensive Insulin—The Epicenter of a Large, Life-Threatening ProblemNally LM, Lipska KJ. Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem. JAMA Internal Medicine 2020, 180: 931-933. PMID: 32478822, DOI: 10.1001/jamainternmed.2020.1299.
- The dawn of automated insulin delivery: from promise to product8. Nally, LM, Sherr, JL. (2020) “Chapter 16. The Dawn of Automated Insulin Delivery: From Promise to Product.” In Fabris (Ed.), Glucose Monitoring Devices: Measuring Blood Glucose to Manage and Control Diabetes (pp.237-356). Philadelphia, PA: Elsevier.
- Chapter 16 The dawn of automated insulin delivery: from promise to productNally L, Sherr J. Chapter 16 The dawn of automated insulin delivery: from promise to product. 2020, 327-356. DOI: 10.1016/b978-0-12-816714-4.00016-8.
- Wilderness Medical Society Clinical Practice Guidelines for Diabetes ManagementVanBaak KD, Nally LM, Finigan RT, Jurkiewicz CL, Burnier AM, Conrad BP, Khodaee M, Lipman GS. Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management. Wilderness And Environmental Medicine 2019, 30: s121-s140. PMID: 31753543, PMCID: PMC7510348, DOI: 10.1016/j.wem.2019.10.003.
- Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use SettingEkhlaspour L, Nally LM, El-Khatib FH, Ly TT, Clinton P, Frank E, Tanenbaum ML, Hanes SJ, Selagamsetty RR, Hood K, Damiano ER, Buckingham BA. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. Journal Of Diabetes Science And Technology 2019, 13: 1001-1007. PMID: 31470740, PMCID: PMC6835195, DOI: 10.1177/1932296819872225.
- 2401-PUB: High Rates of Unrecognized Ketosis in Youth with T1D and Elevated A1c LevelsNALLY L, ELAHI S, VAN NAME M, STEFFEN A, TICHY E, URBAN A, WEYMAN K, TAMBORLANE W. 2401-PUB: High Rates of Unrecognized Ketosis in Youth with T1D and Elevated A1c Levels. Diabetes 2019, 68 DOI: 10.2337/db19-2401-pub.
- 80-LB: Effect of a Behavioral Economics Intervention on Adherence and Glycemic Outcomes in Youth with T1DNALLY L, WAGNER J, VAN NAME M, SHERR J, ZAJAC K, FINNEGAN J, TAMBORLANE W. 80-LB: Effect of a Behavioral Economics Intervention on Adherence and Glycemic Outcomes in Youth with T1D. Diabetes 2019, 68 DOI: 10.2337/db19-80-lb.
- Pharmacologic treatment options for type 1 diabetes: what’s new?Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Pharmacologic treatment options for type 1 diabetes: what’s new? Expert Review Of Clinical Pharmacology 2019, 12: 471-479. PMID: 30892094, PMCID: PMC6488361, DOI: 10.1080/17512433.2019.1597705.
- A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose MonitoringNally LM, Bondy N, Doiev J, Buckingham BA, Wilson DM. A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2019, 21: 170-176. PMID: 30839229, DOI: 10.1089/dia.2018.0337.
- A Feasibility Study to Detect Neonatal Hypoglycemia Using Real-Time Continuous Glucose MonitoringNALLY L, BONDY N, DOIEV J, BUCKINGHAM B, WILSON D. A Feasibility Study to Detect Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring. Diabetes 2018, 67 DOI: 10.2337/db18-906-p.
- Case 3: An Infant with Severe Dehydration, Weight Loss, and Abnormal Newborn Screening Test ResultsWas A, Lee H, Nally L, Arain Y. Case 3: An Infant with Severe Dehydration, Weight Loss, and Abnormal Newborn Screening Test Results. NeoReviews 2018, 19: e48-e50. DOI: 10.1542/neo.19-1-e48.
- Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice.Li R, Buras E, Lee J, Liu R, Liu V, Espiritu C, Ozer K, Thompson B, Nally L, Yuan G, Oka K, Chang B, Samson S, Yechoor V, Chan L. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice. Gene Therapy 2015, 22: 876-82. PMID: 26172077, PMCID: PMC4636470, DOI: 10.1038/gt.2015.62.
Clinical Trials
| Conditions | Study Title |
|---|---|
| Diabetes Mellitus - Type 1 | Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes |
| Children's Health; Diabetes Mellitus - Type 1 | Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System |
| Diabetes Mellitus - Type 1 | Medtronic CIP335 study for Type I Diabetes |